Document is current
Any future updates will be listed below
-
Authors
Traub, Rebecca
Rubinstein, Samuel M.
Dittus, Christopher
- License Information
-
More Information
Article History
Accepted: 16 June 2025
First Online: 23 June 2025
Declarations
:
: Rebecca Traub has received research funding and consulting fees from Argenx, research funding from Immunovant and consulting fees from Takeda. Samuel Rubinstein has received consulting fees from Johnson&Johnson, Brisol-Myers Squibb, and Sanofi. Christopher Dittus has received research funding from Segan, Genentech, and Astrazeneca and consulting fees from Beigene, Genmab, and ADC.
